News & Updates

Long-acting ART induces viral suppression in people with HIV
Long-acting ART induces viral suppression in people with HIV
15 Jul 2023

People with HIV (PWH) who are treated with long-acting (LA) antiretroviral therapy (ART) achieve virologic suppression, as do those with viraemia and challenges to adherence, reports a study.

Long-acting ART induces viral suppression in people with HIV
15 Jul 2023
Ustekinumab safe, effective in Asians with moderate to severe plaque psoriasis
Ustekinumab safe, effective in Asians with moderate to severe plaque psoriasis
14 Jul 2023
Virtual ward feasible home-based care strategy for high-risk COVID-19 patients
Virtual ward feasible home-based care strategy for high-risk COVID-19 patients
07 Jul 2023
Add-on fluvoxamine of no benefit in mild-to-moderate COVID-19
Add-on fluvoxamine of no benefit in mild-to-moderate COVID-19
07 Jul 2023

In the treatment of patients with mild-to-moderate COVID-19, adding fluvoxamine to favipiravir does not appear to prevent disease progression or improve certain outcomes, according to the results of an open-label study.

Add-on fluvoxamine of no benefit in mild-to-moderate COVID-19
07 Jul 2023
More evidence for COVID-19 vaccine safety in kids
More evidence for COVID-19 vaccine safety in kids
05 Jul 2023

COVID-19 vaccines can be safely administered in children, with a recent study showing that out of the numerous health outcomes monitored in near real time, the safety signal identified was for only myocarditis or pericarditis.

More evidence for COVID-19 vaccine safety in kids
05 Jul 2023
COVID outcomes worse in polluted cities
COVID outcomes worse in polluted cities
01 Jul 2023